China ophthalmic laser market is forecast to grow at a CAGR of 7.0% during the forecast period and is expected to reach around $104 million in 2025 as compared to $65 million in 2018. The market in China is driven by numerous factors including increasing government initiatives such as the National Programme for Control of Blindness, and the rising cataract-removal surgeries. Population-based surveys in China have identified cataract as the leading cause of blindness and visual impairment. Cataract surgery using ophthalmic laser is an effective means to reverse cataract blindness. However, in 2017, according to NCBI NLM, the cataract surgical rate (CSR) in China remains relatively low at about 772 cases per million per year. A major cause of low CSR is the lack of experienced surgeons in rural areas. The Chinese Ministry of Health has reported that 45% of China’s 2,400 country’s hospitals do not offer cataract surgery services and most rural residents are unable to afford surgery in urban centers.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/china-ophthalmic-lasers-market
On this account various projects were intended, such as Project Vision, a non-governmental organization, to build a sustainable model to reduce cataract blindness in rural China. Project Vision’s first priority is to develop rural charity eye centers wherein local doctors are trained to provide high quality and low-cost cataract surgery. Besides, the government initiated the “One Million Cataract Blindness Project” in 2009 to provide free cataract surgeries, with additional financial and medical support from non-government organizations. According to the International Council of Ophthalmology, there were 37,000 ophthalmologists in China in 2018, which is 26 per million.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/china-ophthalmic-lasers-market
The China ophthalmic lasers market is segmented on the basis of type, application, and end-user. Based on the type, the market is further classified into SLT laser, Nd: YAG laser, excimer laser, femtosecond laser, cyclodiode laser, and others. There are multiple applications for Nd: YAG lasers and is most commonly used for the treatment of posterior capsular opacification after cataract surgery. Other applications comprise the treatment of recurrent vitreous floaters and corneal erosions. Additionally, based on application, the market is further classified into cataract surgery, refractive surgery, AMD, cornea transplant surgery, glaucoma surgery, diabetic retinopathy, and others. Based on end-user, the market is further classified into hospital, clinic and ambulatory surgical center.
Market Segmentation
China Ophthalmic Lasers Market by Type
- Excimer Laser
- Femtosecond Laser
- Cyclodiode Laser
- Nd: YAG Laser
- Selective-Laser-Trabeculoplasty (SLT) Laser
- Others
China Ophthalmic Lasers Market by Application
- Cataract Surgery
- Glaucoma Surgery
- Diabetic Retinopathy
- Refractive Surgery
- Age-Related Macular Degeneration (AMD)
- Cornea Transplant Surgery
- Others
China Ophthalmic Lasers Market by End-User
- Hospital
- Clinic
- Ambulatory Surgical Center
COMPANY PROFILES
- Bausch & Lomb, Inc.
- Boston Scientific Corp.
- Carl Zeiss Meditec AG
- Johnson & Johnson, Service Inc.
- NIDEK Co., Ltd.
- Novartis International AG
- Quantel Medical
- SCHWIND Eye Tech Solutions GmbH
- Topcon Medical Systems, Inc.
- Ziemer Ophthalmic Systems AG
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-ophthalmic-lasers-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
